Richard G White
机构: Professor of Infectious Disease Modelling, London School of Hygiene and Tropical Medicine
主页: lshtm.ac.uk
每年引用次数
引用次数
引用: 14,526
H-指数: 58
I10-指数 : 157
出版物: 314
A novel blood test for tuberculosis prevention and treatment
Adam Penn-Nicholson , Thomas J Scriba , Mark Hatherill , Richard G White
SAMJ: South African Medical Journal 107 ( 1) 4 -5
16
2017
Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens
Arminder K Deol , Danny Scarponi , Peter Beckwith , Tom A Yates
Plos one 16 ( 6) e0253096 -e0253096
12
2021
Developing whole mycobacteria cell vaccines for tuberculosis
Stefan HE Kaufmann , Barry Bloom , Roland Brosch , Pere Joan Cardona Iglesias
Vaccine 33 ( 26) 3047 -3055
12
2015
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case
Sonali Kochhar , Draurio Barreira , Pauline Beattie , Marco Cavaleri
Vaccine 40 ( 12) 1681 -1690
10
2022
Modelling the effect of infection prevention and control measures on rate of Mycobacterium tuberculosis transmission to clinic attendees in primary health clinics in South Africa
Nicky McCreesh , Aaron S Karat , Kathy Baisley , Karin Diaconu
BMJ Global Health 6 ( 10) e007124 -e007124
10
2021
Emulation and History Matching using the hmer Package
Andrew Iskauskas , Ian Vernon , Michael Goldstein , Danny Scarponi
arXiv preprint arXiv:2209.05265
7
2022
End-point definition and trial design to advance tuberculosis vaccine development
Alberto L Garcia-Basteiro , Richard G White , Dereck Tait , Alexander C Schmidt
European Respiratory Review 31 ( 164)
7
2022
Empirical observations underestimate the proportion of HIV infections attributable to sexually transmitted diseases in Mwanza and Rakai STD treatment trials: Simulation results-Response to Gray's letter
Kate K Orroth , Richard G White , Richard J Hayes
SEXUALLY TRANSMITTED DISEASES 34 62 -62
7
2007
The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study
Tom Sumner , Simon C Mendelsohn , Thomas J Scriba , Mark Hatherill
BMC medicine 19 1 -11
6
2021
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel
Maurine D Miner , Mark Hatherill , Vidya Mave , Glenda E Gray
The Lancet HIV 9 ( 11) e791 -e800
5
2022
Sociological variety and the transmission efficiency of Mycobacterium tuberculosis: a secondary analysis of qualitative and quantitative data from 15 communities in Zambia
Emma J Murray , Peter J Dodd , Ben Marais , Helen Ayles
BMJ open 11 ( 12) e047136 -e047136
4
2021
An aspiration to radically shorten phase 3 tuberculosis vaccine trials
Philip C Hill , Frank Cobelens , Leonardo Martinez , Marcel A Behr
The Journal of Infectious Diseases 228 ( 9) 1150 -1153
3
2023
The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosis
Kerry A Millington , Richard G White , Marc Lipman , C Finn McQuaid
The Lancet Respiratory Medicine 12 ( 1) 10 -13
2
2024
Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment
Molebogeng X Rangaka , Mike Frick , Gavin Churchyard , Alberto L García-Basteiro
The Lancet Respiratory Medicine 11 ( 4) 380 -390
2
2023
Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity
John Benest , Sophie Rhodes , Thomas G Evans , Richard G White
Vaccines 10 ( 5) 756 -756
2
2022
Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination
Chathika Krishan Weerasuriya , Rebecca Claire Harris , Christopher Finn McQuaid , Gabriela B Gomez
PLOS Computational Biology 18 ( 4) e1010002 -e1010002
2
2022
Mathematical modelling to estimate the impact of age of BCG vaccination on global paediatric TB mortality
Partho S Roy , Richard G White , Rebecca C Harris ,
2
2017
Improving the quality of the Global Burden of Disease tuberculosis estimates from the Institute for Health Metrics and Evaluation
Peter J Dodd , Christopher Finn McQuaid , Prasada Rao , Ibrahim Abubakar
International journal of epidemiology 52 ( 6) 1681 -1686
1
2023
The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design
John Benest , Sophie Rhodes , Thomas G Evans , Richard G White
Vaccines 10 ( 11) 1838 -1838
1
2022
Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
Chathika K Weerasuriya , Rebecca C Harris , C Finn McQuaid , Fiammetta Bozzani
BMC medicine 20 ( 1) 99 -99
1
2022